12.89
-0.10 (-0.77%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Oric Pharmaceuticals, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -4.5 |
| Technical Moving Averages | -5.0 |
| Technical Oscillators | -0.5 |
| Average | -2.88 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 7.93% |
| % Held by Institutions | 102.70% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Aihc Capital Management Ltd | 30 Jun 2026 | 3,828,460 |
| Column Group Llc | 30 Jun 2026 | 3,540,777 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| PISCITELLI DOMINIC | - | 13.91 | -77,000 | -1,071,070 |
| Aggregate Net Quantity | -77,000 | |||
| Aggregate Net Value ($) | -1,071,070 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 13.91 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PISCITELLI DOMINIC | Officer | 26 Aug 2026 | Automatic sell (-) | 77,000 | 13.91 | 1,071,070 |
| PISCITELLI DOMINIC | Officer | 26 Aug 2026 | Option execute | 77,000 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |